Copyright Reports & Markets. All rights reserved.

Global Hospital-Acquired Infection Control Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Hospital-Acquired Infection Control Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Hospital-Acquired Infection Control Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Catheter-associated urinary tract infections (CAUTIs)
      • 1.4.3 Surgical site infections (SSIs)
      • 1.4.4 Central line-associated bloodstream infections (CLABSIs)
      • 1.4.5 Respiratory infections
    • 1.5 Market by Application
      • 1.5.1 Global Hospital-Acquired Infection Control Market Share by Application: 2020 VS 2026
      • 1.5.2 Hospitals and ICUs
      • 1.5.3 Outpatient care centers
      • 1.5.4 Long-term care facilities (LTCFs)
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Hospital-Acquired Infection Control Market Perspective (2015-2026)
    • 2.2 Hospital-Acquired Infection Control Growth Trends by Regions
      • 2.2.1 Hospital-Acquired Infection Control Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Hospital-Acquired Infection Control Historic Market Share by Regions (2015-2020)
      • 2.2.3 Hospital-Acquired Infection Control Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Hospital-Acquired Infection Control Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Hospital-Acquired Infection Control Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Hospital-Acquired Infection Control Players by Market Size
      • 3.1.1 Global Top Hospital-Acquired Infection Control Players by Revenue (2015-2020)
      • 3.1.2 Global Hospital-Acquired Infection Control Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Hospital-Acquired Infection Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Hospital-Acquired Infection Control Market Concentration Ratio
      • 3.2.1 Global Hospital-Acquired Infection Control Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Infection Control Revenue in 2019
    • 3.3 Hospital-Acquired Infection Control Key Players Head office and Area Served
    • 3.4 Key Players Hospital-Acquired Infection Control Product Solution and Service
    • 3.5 Date of Enter into Hospital-Acquired Infection Control Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Hospital-Acquired Infection Control Historic Market Size by Type (2015-2020)
    • 4.2 Global Hospital-Acquired Infection Control Forecasted Market Size by Type (2021-2026)

    5 Hospital-Acquired Infection Control Breakdown Data by Application (2015-2026)

    • 5.1 Global Hospital-Acquired Infection Control Market Size by Application (2015-2020)
    • 5.2 Global Hospital-Acquired Infection Control Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Hospital-Acquired Infection Control Market Size (2015-2020)
    • 6.2 Hospital-Acquired Infection Control Key Players in North America (2019-2020)
    • 6.3 North America Hospital-Acquired Infection Control Market Size by Type (2015-2020)
    • 6.4 North America Hospital-Acquired Infection Control Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Hospital-Acquired Infection Control Market Size (2015-2020)
    • 7.2 Hospital-Acquired Infection Control Key Players in Europe (2019-2020)
    • 7.3 Europe Hospital-Acquired Infection Control Market Size by Type (2015-2020)
    • 7.4 Europe Hospital-Acquired Infection Control Market Size by Application (2015-2020)

    8 China

    • 8.1 China Hospital-Acquired Infection Control Market Size (2015-2020)
    • 8.2 Hospital-Acquired Infection Control Key Players in China (2019-2020)
    • 8.3 China Hospital-Acquired Infection Control Market Size by Type (2015-2020)
    • 8.4 China Hospital-Acquired Infection Control Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Hospital-Acquired Infection Control Market Size (2015-2020)
    • 9.2 Hospital-Acquired Infection Control Key Players in Japan (2019-2020)
    • 9.3 Japan Hospital-Acquired Infection Control Market Size by Type (2015-2020)
    • 9.4 Japan Hospital-Acquired Infection Control Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Hospital-Acquired Infection Control Market Size (2015-2020)
    • 10.2 Hospital-Acquired Infection Control Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Hospital-Acquired Infection Control Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Hospital-Acquired Infection Control Market Size by Application (2015-2020)

    11 India

    • 11.1 India Hospital-Acquired Infection Control Market Size (2015-2020)
    • 11.2 Hospital-Acquired Infection Control Key Players in India (2019-2020)
    • 11.3 India Hospital-Acquired Infection Control Market Size by Type (2015-2020)
    • 11.4 India Hospital-Acquired Infection Control Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Hospital-Acquired Infection Control Market Size (2015-2020)
    • 12.2 Hospital-Acquired Infection Control Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Hospital-Acquired Infection Control Market Size by Type (2015-2020)
    • 12.4 Central & South America Hospital-Acquired Infection Control Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 GlaxoSmithKline
      • 13.1.1 GlaxoSmithKline Company Details
      • 13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
      • 13.1.3 GlaxoSmithKline Hospital-Acquired Infection Control Introduction
      • 13.1.4 GlaxoSmithKline Revenue in Hospital-Acquired Infection Control Business (2015-2020))
      • 13.1.5 GlaxoSmithKline Recent Development
    • 13.2 Merck
      • 13.2.1 Merck Company Details
      • 13.2.2 Merck Business Overview and Its Total Revenue
      • 13.2.3 Merck Hospital-Acquired Infection Control Introduction
      • 13.2.4 Merck Revenue in Hospital-Acquired Infection Control Business (2015-2020)
      • 13.2.5 Merck Recent Development
    • 13.3 Pfizer
      • 13.3.1 Pfizer Company Details
      • 13.3.2 Pfizer Business Overview and Its Total Revenue
      • 13.3.3 Pfizer Hospital-Acquired Infection Control Introduction
      • 13.3.4 Pfizer Revenue in Hospital-Acquired Infection Control Business (2015-2020)
      • 13.3.5 Pfizer Recent Development
    • 13.4 3M
      • 13.4.1 3M Company Details
      • 13.4.2 3M Business Overview and Its Total Revenue
      • 13.4.3 3M Hospital-Acquired Infection Control Introduction
      • 13.4.4 3M Revenue in Hospital-Acquired Infection Control Business (2015-2020)
      • 13.4.5 3M Recent Development
    • 13.5 Abbott
      • 13.5.1 Abbott Company Details
      • 13.5.2 Abbott Business Overview and Its Total Revenue
      • 13.5.3 Abbott Hospital-Acquired Infection Control Introduction
      • 13.5.4 Abbott Revenue in Hospital-Acquired Infection Control Business (2015-2020)
      • 13.5.5 Abbott Recent Development
    • 13.6 BD
      • 13.6.1 BD Company Details
      • 13.6.2 BD Business Overview and Its Total Revenue
      • 13.6.3 BD Hospital-Acquired Infection Control Introduction
      • 13.6.4 BD Revenue in Hospital-Acquired Infection Control Business (2015-2020)
      • 13.6.5 BD Recent Development
    • 13.7 Cepheid
      • 13.7.1 Cepheid Company Details
      • 13.7.2 Cepheid Business Overview and Its Total Revenue
      • 13.7.3 Cepheid Hospital-Acquired Infection Control Introduction
      • 13.7.4 Cepheid Revenue in Hospital-Acquired Infection Control Business (2015-2020)
      • 13.7.5 Cepheid Recent Development
    • 13.8 Getinge Group
      • 13.8.1 Getinge Group Company Details
      • 13.8.2 Getinge Group Business Overview and Its Total Revenue
      • 13.8.3 Getinge Group Hospital-Acquired Infection Control Introduction
      • 13.8.4 Getinge Group Revenue in Hospital-Acquired Infection Control Business (2015-2020)
      • 13.8.5 Getinge Group Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global Hospital-Acquired Infection Control status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hospital-Acquired Infection Control development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      GlaxoSmithKline
      Merck
      Pfizer
      3M
      Abbott
      BD
      Cepheid
      Getinge Group

      Market segment by Type, the product can be split into
      Catheter-associated urinary tract infections (CAUTIs)
      Surgical site infections (SSIs)
      Central line-associated bloodstream infections (CLABSIs)
      Respiratory infections
      Market segment by Application, split into
      Hospitals and ICUs
      Outpatient care centers
      Long-term care facilities (LTCFs)

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Hospital-Acquired Infection Control status, future forecast, growth opportunity, key market and key players.
      To present the Hospital-Acquired Infection Control development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Hospital-Acquired Infection Control are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now